CVS Caremark Extends Pharmacy Advisor™ Program to Cover Five Additional Chronic Conditions

   CVS Caremark Extends Pharmacy Advisor™ Program to Cover Five Additional
                              Chronic Conditions

Intervention program increases patient engagement, reduces medical costs
through improved medication adherence

PR Newswire

WOONSOCKET, R.I., Feb. 7, 2013

WOONSOCKET, R.I., Feb. 7, 2013 /PRNewswire/ -- CVS Caremark (NYSE: CVS) has
extended its innovative Pharmacy Advisor™ program to cover an additional five
chronic conditions, including asthma, breast cancer, chronic obstructive
pulmonary disease, depression, and osteoporosis. The condition-based program
alerts pharmacists when patients are not adherent to their medication regimens
or have a gap in care, allowing them to intervene with patients and
communicate with their physicians in real time. Before this program
extension, the Pharmacy Advisor program had focused on patients with diabetes
or cardiovascular conditions, with more than 3.8 million interventions
conducted to date.


It is estimated that medication nonadherence costs the U.S. economy nearly
$300 billion annually. Studies suggest that poor medication adherence is
linked to chronic conditions, and that medication persistence – the length of
time a patient continues to take a prescribed drug – tends to be low for those
with chronic conditions. Research also suggests that the design of medically
appropriate regimens for individual patients can play a role in improving
costs and outcomes associated with adherence,^1 and that intervention by
pharmacists can reduce gaps in care.^2

"We are delighted to extend Pharmacy Advisor and its benefits to patients
managing medications associated with additional chronic conditions," said
Troyen A. Brennan, MD, MPH, Executive Vice President and Chief Medical Officer
of CVS Caremark. "Pharmacists play an important role in the coordination of
care for individuals living with chronic conditions and understand how
critical medication adherence is in supporting their patients."

In addition to improving medication adherence, Pharmacy Advisor directs
members with chronic conditions to existing disease management programs where
they can obtain additional support.

"Pharmacy Advisor not only improves quality of care for individuals with
chronic conditions by providing an additional layer of support, it also
addresses the important systemic challenges of health care costs related to
medication nonadherence," said Jon Roberts, President of CVS Caremark's
Pharmacy Benefits Management business. "Extending the program to cover a
broader range of chronic conditions expands our ability to support even more
patients on their path to better health, while reducing the burden of cost
associated with medication non-adherence for patients with these conditions."

About CVS Caremark
CVS Caremark is dedicated to helping people on their path to better health as
the largest integrated pharmacy company in the United States. Through the
company's more than 7,400 CVS/pharmacy stores; its leading pharmacy benefit
manager serving more than 60 million plan members; and its retail health
clinic system, the largest in the nation with more than 600 MinuteClinic
locations, it is a market leader in mail order, retail and specialty pharmacy,
retail clinics, and Medicare Part D Prescription Drug Plans. As a pharmacy
innovation company with an unmatched breadth of capabilities, CVS Caremark
continually strives to improve health and lower costs by developing new
approaches such as its unique Pharmacy Advisor program that helps people with
chronic diseases such as diabetes obtain and stay on their medications. Find
more information about how CVS Caremark is reinventing pharmacy for better
health at


 Media Contacts:
 Christine K. Cramer              Maura Mone
 CVS Caremark                     CVS Caremark
 401-770-3317                     401-770-6351

^1New England Healthcare Institute (2009).  Thinking Outside the Pillbox: A
System-wide Approach to Improving Patient Medication Adherence for Chronic
Disease. NEHI Research Brief, August 2009.

^2 Brennan et al. (2012). An Integrated Pharmacy-Based Program Improved
Medication Prescription and Adherence Rates in Diabetes Patients. Health
Affairs. 31(1).


Press spacebar to pause and continue. Press esc to stop.